‹ All Posts
Saurabh Tyagi--Clovek,Advisory

19th Feb · SEBI-Registered Analyst

ZYDUSLIFE

ZYDUSLIFE
launches Anyra, India's first indigenously developed biosimilar of Aflibercept 2 mg. Indicated for neovascular (wet) Age-related Macular Degeneration and other eye diseases, Anyra was developed by Zydus Lifesciences Ltd. The drug's launch aligns with Zydus Life's mission to make advanced biologics accessible to patients in India.

#TrendingSectors#FundamentalViews#StockInNews#MacroViews#EquityResearch
1,021 likes·51 comments